Intravenous Palifosfamide-tris in Combination With Etoposide and Carboplatin in Patients With Malignancies



Status:Archived
Conditions:Lung Cancer, Ovarian Cancer, Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:November 2010
End Date:July 2011

Use our guide to learn which trials are right for you!

A Phase I Study of Intravenous (IV) Palifosfamide-tris Administered in Combination With IV Etoposide and IV Carboplatin in Patients With Malignancies for Which Etoposide and Carboplatin Are an Appropriate Choice


This an an open-label study to define the safety profile and the maximum tolerated dose and
confirm the clinical effective dose of palifosfamide-tris given intravenously in combination
with etoposide and carboplatin in a wide range of cancers which etoposide and carboplatin
are normally given. Once the maximum dose of palifosfamide-tris is determined,a Phase II
study using the 3 agents combined will begin.



We found this trial at
4
sites
Lafayette, Indiana 47905
?
mi
from
Lafayette, IN
Click here to add this to my saved trials
1 Brookings Drive
St. Louis, Missouri 63110
 (314) 935-5000
Washington University Washington University creates an environment to encourage and support an ethos of wide-ranging...
?
mi
from
St. Louis, MO
Click here to add this to my saved trials
Indianapolis, Indiana 46202
?
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Muncie, Indiana 47303
?
mi
from
Muncie, IN
Click here to add this to my saved trials